CliffBio
small molecule

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

GLIPIZIDE; METFORMIN HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyNovitium Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand nameGLIPIZIDE AND METFORMIN HYDROCHLORIDE
Active ingredientGLIPIZIDE; METFORMIN HYDROCHLORIDE
Strength2.5MG;500MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2007
Marketing statusDISCN

More from Novitium Pharma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.